Related Experiment Videos
Non-specific host defence stimulation and antibiotic-resistant infection
The Journal of Antimicrobial Chemotherapy
|October 1, 1983
Summary
Combining clindamycin with muramyl dipeptide (MDP) significantly reduced E. coli bacteraemia in a surgical infection model. This host defense stimulation enhanced bacterial susceptibility to MDP, despite increased local bacterial recovery.
Area of Science:
- Infectious Diseases
- Pharmacology
- Immunology
Background:
- Surgical infections pose significant clinical challenges.
- Understanding host-pathogen interactions is crucial for developing effective treatments.
- Subinhibitory antibiotic concentrations can influence bacterial susceptibility and host immune responses.
Purpose of the Study:
- To investigate the combined effect of subinhibitory clindamycin and muramyl dipeptide (MDP) on Escherichia coli surgical infection in an animal model.
- To evaluate the impact of this combination therapy on bacterial load and systemic spread.
Main Methods:
- An animal model of surgical infection was established using Escherichia coli.
- Animals were treated with clindamycin alone, MDP alone, or a combination of both.
- Bacteraemia and local bacterial recovery were quantified at timed intervals post-challenge.
Main Results:
- Clindamycin alone did not significantly alter bacterial recovery or bacteraemia compared to placebo.
- The combination of MDP and clindamycin significantly reduced bacteraemia compared to either agent alone.
- Paradoxically, local bacterial recovery was higher in the combined treatment group.
Conclusions:
- Subinhibitory clindamycin enhances the efficacy of host defense stimulation by MDP against systemic E. coli infection.
- The combination therapy shows promise in controlling bacteraemia, suggesting a synergistic effect.
- Further research is warranted to elucidate the mechanisms behind increased local bacterial recovery.